Skip to main content

Table 2 Anticancer drugs handled by APOTECAchemo

From: Performance evaluation of the compounding robot, APOTECAchemo, for injectable anticancer drugs in a Japanese hospital

Ingredient

Content (mg)

Ingredient

Content (mg)

Amrubicin Hydrochloride

20, 50

Ifosfamide

1000

Bendamustine Hydrochloride

100

Irinotecan Hydrochloride Hydrate

40, 100

Bevacizumab

(Genetical Recombination)

100, 400

L-Asparaginase

5000 U

Carboplatin

50, 150, 450

Methotrexate

50, 200, 1000

Cetuximab

(Genetical Recombination)

100

Oxaliplatin

50, 100, 200

Cisplatin

10, 25, 50

Paclitaxel

30, 100

Cyclophosphamide Hydrate

100, 500

nab-Paclitaxel (abraxane)

100

Cytarabine

1000

Panitumumab

(Genetical Recombination)

100

Dacarbazine

100

Pemetrexed Sodium Hydrate

100, 500

Daunorubicin Hydrochloride

20

Pertuzumab

(Genetical Recombination)

420

Docetaxel

20, 80

Pirarubicin

10, 20

Doxorubicin Hydrochloride

10, 50

Ramucirumab

100

Doxorubicin Hydrochloride

20

Rituximab

(Genetical Recombination)

100, 500

Epirubicin Hydrochloride

10, 50

Temozolomide

100

Etoposide

100

Trastuzumab

(Genetical Recombination)

150

Fluorouracil

250, 1000

Vincristine Sulfate

1

Gemcitabine Hydrochloride

200, 1000

Vinorelbine Ditartrate

10, 40